Development and application of a pediatric mechanistic kidney model by Farzaneh Salem, Ben G. Small, Trevor N. Johnson

Connect to this object online.

Physiologically Based Pharmacokinetics Modeling in the Neonatal Population-Current Advances, Challenges, and Opportunities by Jean Dinh, Trevor N. Johnson, Manuela Grimstein, Tamorah Lewis

Connect to this object online.

Increasing application of pediatric physiologically based pharmacokinetic models across academic and industry organizations by Trevor N. Johnson, Ben G. Small, Karen Rowland Yeo

Connect to this object online.

Physiologically Based Pharmacokinetic Modelling to Predict Imatinib Exposures in Cancer Patients with Renal Dysfunction: A Case Study by Karen Rowland Yeo, Oliver Hatley, Ben G. Small, Trevor N. Johnson

Connect to this object online.

A best practice framework for applying physiologically‐based pharmacokinetic modeling to pediatric drug development by Trevor N. Johnson, Ben G. Small, Eva Gil Berglund, Karen Rowland Yeo

Connect to this object online.

Combining data on the bioavailability of midazolam and physiologically‐based pharmacokinetic modeling to investigate intestinal CYP3A4 ontogeny by Trevor N. Johnson, Hannah K. Batchelor, Jan Goelen, Richard D. Horniblow, Jean Dinh

Connect to this object online.

Using a Vancomycin PBPK Model in Special Populations to Elucidate Case‐Based Clinical PK Observations by Chie Emoto, Trevor N. Johnson, Brooks T. McPhail, Alexander A. Vinks, Tsuyoshi Fukuda

Connect to this object online.

PBPK Model of Morphine Incorporating Developmental Changes in Hepatic OCT1 and UGT2B7 Proteins to Explain the Variability in Clearances in Neonates and Small Infants by Chie Emoto, Trevor N. Johnson, Sibylle Neuhoff, David Hahn, Alexander A. Vinks, Tsuyoshi Fukuda

Connect to this object online.

A Theoretical Physiologically‐Based Pharmacokinetic Approach to Ascertain Covariates Explaining the Large Interpatient Variability in Tacrolimus Disposition by Chie Emoto, Trevor N. Johnson, David Hahn, Uwe Christians, Rita R. Alloway, Alexander A. Vinks, Tsuyoshi Fukuda

Connect to this object online.

Forecasting Fetal Buprenorphine Exposure through Maternal-Fetal Physiologically Based Pharmacokinetic Modeling by Matthijs W. van Hoogdalem, Ryota Tanaka, Khaled Abduljalil, Trevor N. Johnson, Scott L. Wexelblatt, Henry T. Akinbi, Alexander A. Vinks, Tomoyuki Mizuno

Connect to this object online.

A guide to developing population files for physiologically‐based pharmacokinetic modeling in the Simcyp Simulator by Liam Curry, Sarah Alrubia, Frederic Y. Bois, Ruth Clayton, Eman El‐Khateeb, Trevor N. Johnson, Muhammad Faisal, Sibylle Neuhoff, Kris Wragg, Amin Rostami‐Hodjegan

Connect to this object online.

Are body surface area based estimates of liver volume applicable to children with overweight or obesity? An in vivo validation study by Chelsea Hosey‐Cojocari, Sherwin S. Chan, Chance S. Friesen, Amie Robinson, Veronica Williams, Erica Swanson, Daniel O'Toole, Jansynn Radford, Neil Mardis, Trevor N. Johnson, J. Steven Leeder, Valentina Shakhnovich

Connect to this object online.

Insights in the maturational processes influencing hydrocortisone pharmacokinetics in congenital adrenal hyperplasia patients using a middle-out approach by Robin Michelet, Davide Bindellini, Davide Bindellini, Johanna Melin, Johanna Melin, Uta Neumann, Oliver Blankenstein, Wilhelm Huisinga, Trevor N. Johnson, Martin J. Whitaker, Richard Ross, Richard Ross, Charlotte Kloft

Connect to this object online.

Pediatric Pharmacokinetics and Dose Predictions: A Report of a Satellite Meeting to the 10th Juvenile Toxicity Symposium by Bianca D. vanGroen, Venkatesh Pilla Reddy, Justine Badée, Andrés Olivares‐Morales, Trevor N. Johnson, Johan Nicolaï, Pieter Annaert, Anne Smits, Saskia N. deWildt, Catherijne A. J. Knibbe, Loeckie deZwart

Connect to this object online.